Revelation Biosciences

(NASDAQ) REVB

Current Price$1.10

Market Cap$4.26M

Since IPO (2020)-100%

5 Year-100%

1 Year-96%

1 Month-6%

Revelation Biosciences Financials at a Glance

Market Cap

$4.26M

Revenue (TTM)

$0.00

Net Income (TTM)

$9.87M

EPS (TTM)

$-39.47

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$1.10

Volume

300

Open

$1.10

Price

$1.10

Volume

300

Open

$1.10

Previous Close

$1.09

Daily Range

$1.10 - $1.10

52-Week Range

$0.88 - $32.16

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$1.10

Volume

300

Open

$1.10

Previous Close

$1.09

Daily Range

$1.10 - $1.10

52-Week Range

$0.88 - $32.16

REVB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Revelation Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

James M. Rolke

Website

www.revbiosciences.com

Headquarters

San Diego, CA 92122, US

REVB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-124%

Return on Capital

-74%

Return on Assets

-66%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.26M

Shares Outstanding

3.91M

Volume

300

Avg. Volume

79.91K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.07M

EBITDA

$9.04M

Operating Cash Flow

$8.27M

Capital Expenditure

$0.00

Free Cash Flow

$8.27M

Cash & ST Invst.

$10.70M

Total Debt

$746.78K

Revelation Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$7.20K

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.26M

N/A

Market Cap/Employee

$532.52K

N/A

Employees

N/A

Net Income

$3.01M

-46.7%

EBITDA

$3.09M

-47.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$13.35M

+260.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$638.18K

N/A

Short Term Debt

$120.86K

N/A

Return on Assets

-65.62%

N/A

Return on Invested Capital

-73.88%

N/A

Free Cash Flow

$3.29M

-17.6%

Operating Cash Flow

$3.21M

-15.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.42+1.22%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

INDPIndaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.$0.97-21.13%

ATXIAvenue Therapeutics, Inc.

ATXIAvenue Therapeutics, Inc.$0.30+8.43%

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

ONCOOnconetix, Inc.

ONCOOnconetix, Inc.$1.17+5.91%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$0.47-11.29%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.74+0.00%

TET1 Energy Inc.

TET1 Energy Inc.$9.20+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.69-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.66+0.01%

RGTZTidal Trust II - Defiance Daily Target 2x Short Rgti ETF

RGTZTidal Trust II - Defiance Daily Target 2x Short Rgti ETF$6.05-0.51%

APLDApplied Digital

APLDApplied Digital$47.17+0.19%

RGTIRigetti Computing

RGTIRigetti Computing$21.35+0.26%

Questions About REVB

What is the current price of Revelation Biosciences?

Revelation Biosciences is trading at $1.10 per share.

What is the 52-week range for Revelation Biosciences?

Over the past 52 weeks, Revelation Biosciences has traded between $0.88 and $32.16.

How much debt does Revelation Biosciences have?

As of the most recent reporting period, Revelation Biosciences reported total debt of $759,044.

How much cash does Revelation Biosciences have on hand?

Revelation Biosciences reported $14.11M in cash and cash equivalents in its most recent financial results.

What is Revelation Biosciences’s dividend yield?

Revelation Biosciences does not currently have a dividend yield.

Revelation Biosciences

Revelation Biosciences Financials at a Glance

REVB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Revelation Biosciences

REVB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Revelation Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About REVB

What is the current price of Revelation Biosciences?

What is the 52-week range for Revelation Biosciences?

How much debt does Revelation Biosciences have?

How much cash does Revelation Biosciences have on hand?

What is Revelation Biosciences’s dividend yield?

Premium Investing Services